openPR Logo
Press release

LAGENIO Announces the A12 PRO as the Leading Large-Battery Smartphone for Everyday Use

08-26-2025 01:40 AM CET | Media & Telecommunications

Press release from: ABNewswire

LAGENIO Announces the A12 PRO as the Leading Large-Battery

In today's fast-paced digital world, finding a smartphone that combines long-lasting performance, advanced features, and affordability is a challenge. LAGENIO [https://shop.lagenio.com/] has made this possible with the A12 PRO, a smartphone designed for users who demand power, style, and efficiency in their everyday lives. With its massive battery, high-end display, and advanced camera setup, the A12 PRO is redefining what people expect from a budget-friendly premium device.

Powerful Performance with Next-Gen Hardware

The LAGENIO A12 PRO is powered by the T7250 Octa-Core processor clocking up to 1.8GHz, ensuring smooth multitasking and efficient power management. Backed with a massive 24GB RAM (8GB physical + 16GB virtual), it delivers seamless performance whether you're gaming, streaming, or running multiple apps. Coupled with a 256GB ROM, you get ample storage for all your apps, photos, videos, and files without worrying about space.

A Battery That Lasts for Days

One of the standout features of the A12 PRO is its 6500mAh long-lasting battery. With up to 39 hours of talk time and an impressive 1200 hours of standby time, this phone is built for users who don't want to be tied to chargers all day. Whether you're traveling, working, or streaming your favorite shows, the A12 PRO ensures your phone stays powered when you need it most.

Stunning Visual Experience

The smartphone comes with a 6.9-inch HD+ Incell Display, offering a 90% screen-to-body ratio for an immersive viewing experience. Its 120Hz refresh rate ensures smoother scrolling, gaming, and video playback. Watching content on this device is enhanced further with Widevine L1 certification, which guarantees HD-quality streaming on popular platforms.

Advanced AI Cameras for Every Moment

The A12 PRO is equipped with a 50MP AI-enhanced rear camera that captures sharp, detailed photos in all conditions. Features like Night Mode, HDR, Portrait, Panorama, and Face Filters make photography enjoyable and versatile. For selfies and video calls, the 8MP AI Beauty Front Camera ensures clear and vibrant results.

Global Connectivity and Seamless Use

Designed for international use, the A12 PRO supports over 20 global frequency bands, ensuring connectivity wherever you go. With dual Nano SIM + TF card support, dual-band Wi-Fi (2.4GHz / 5GHz), and Bluetooth 5.0, this smartphone keeps you connected at all times. The USB Type-C with OTG further enhances convenience.

Security Made Simple

Security is a priority with the A12 PRO. It features multiple unlock options including PIN, Side Fingerprint Scanner, and Face Unlock, giving users flexibility and peace of mind. Regular OTA updates also ensure improved system stability and quarterly security patches.

Built for Everyday Durability

With its ultra-thin 8.55mm body, weighing just 211g, the LAGENIO A12 PRO is lightweight yet durable. It comes in stylish colors - Navy, Blue, and White - making it a smartphone that looks as premium as it performs.

Product Link

Discover more details and purchase directly here: https://shop.lagenio.com/

Media Contact
Company Name: Tirisen Group
Contact Person: LAGENIO
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=lagenio-announces-the-a12-pro-as-the-leading-largebattery-smartphone-for-everyday-use]
Country: Germany
Website: https://shop.lagenio.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release LAGENIO Announces the A12 PRO as the Leading Large-Battery Smartphone for Everyday Use here

News-ID: 4158937 • Views:

More Releases from ABNewswire

Brain Metastases Pipeline 2025: Pioneering Clinical Advancements by 40+ Global Leaders - DelveInsight | Featuring HUYA Bioscience, Kazia Therapeutics, BioMimetix, EpicentRx, Inc., Angiochem, Medolutio
Brain Metastases Pipeline 2025: Pioneering Clinical Advancements by 40+ Global L …
Brain Metastases companies are Betta Pharmaceuticals Co., Ltd., Merck Sharp & Dohme LLC, Bristol-Myers Squibb, 2-BBB Medicines, DEKK-TEC, Inc., Nascent Biotech, Quadriga Biosciences, Inc., Jubilant Therapeutics, Denali Therapeutics Inc, NUVATION BIO, Novocure GmbH, Affinia Therapeutics, Specialised Therapeutics, Precirix, Ashvattha Therapeutics, Cereius, Allarity Therapeutics, TYK Medicine, Surgimab, ORIC Pharmaceuticals, SonALAsense, Nerviano Medical Sciences, Lin Bioscience, and others. With brain metastases increasingly prevalent worldwide and contributing to comorbid conditions such as diabetes, cardiovascular
Anaplastic Thyroid Cancer Pipeline 2025: Innovative Clinical Developments by 8+ Global Leaders - DelveInsight | Featuring companies such as Takeda, Shanghai Henlius Biotech, Taizhou Hanzhong Pharmaceu
Anaplastic Thyroid Cancer Pipeline 2025: Innovative Clinical Developments by 8+ …
DelveInsight's, "Anaplastic Thyroid Cancer - Pipeline Insight, 2025," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Anaplastic Thyroid Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. With anaplastic thyroid cancer increasingly prevalent worldwide and
Cabinets 4 Less Scottsdale Showroom Offers Affordable Cabinetry Solutions
Cabinets 4 Less Scottsdale Showroom Offers Affordable Cabinetry Solutions
Cabinets 4 Less Scottsdale, a premier cabinet store located at 8445 E. McDonald Dr. in Scottsdale, AZ, is expanding its showroom to offer homeowners, contractors, and designers affordable, high-quality cabinetry. With a wide selection of styles and finishes, personalized consultations, and reliable service, the store provides cost-effective solutions for remodeling and construction projects in Scottsdale's growing housing market. SCOTTSDALE, AZ - September 30, 2025 - Cabinets 4 Less Scottsdale [https://cabinets4lessscottsdale.com], a
Hypercholesterolemia Pipeline 2025: Innovative Clinical Advancements by 25+ Global Leaders - DelveInsight | Featuring companies such as Jiangsu HengRui Medicine Co., Ltd., Merck Sharp & Dohme LLC, Arr
Hypercholesterolemia Pipeline 2025: Innovative Clinical Advancements by 25+ Glob …
DelveInsight's, "Hypercholesterolemia- Pipeline Insight, 2025" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hypercholesterolemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. With hypercholesterolemia reaching global epidemic proportions and contributing to comorbid conditions such as

All 5 Releases


More Releases for A12

Respiratory Syncytial Virus Pipeline Drugs 2025 Report: Emerging Drugs, Innovati …
DelveInsight's, "Respiratory Syncytial Virus Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Respiratory Syncytial Virus (RSV) pipeline landscape. It covers the Respiratory Syncytial Virus pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Respiratory Syncytial Virus pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover
Respiratory Syncytial Virus Pipeline Outlook 2025: Clinical Trial Studies, EMA, …
DelveInsight's, "Respiratory Syncytial Virus Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Respiratory Syncytial Virus (RSV) pipeline landscape. It covers the Respiratory Syncytial Virus pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Respiratory Syncytial Virus pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover
Respiratory Syncytial Virus Clinical Trials and Studies 2025: EMA, PDMA, FDA App …
DelveInsight's, "Respiratory Syncytial Virus Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Respiratory Syncytial Virus (RSV) pipeline landscape. It covers the Respiratory Syncytial Virus pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Respiratory Syncytial Virus pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover
Pancreatic Cancer Market to Progress at a CAGR of 7.3 % by 2032 | DelveInsight
DelveInsight's Pancreatic Cancer Market Insights report includes a comprehensive understanding of current treatment practices, pancreatic cancer emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM (the United States, the EU5 (the United Kingdom, Italy, Spain, France, and Germany), and Japan. The pancreatic cancer market is anticipated to show positive growth, mainly attributed to the increasing incident cases and also, the
Pocket Portal Academy conducts Advance Excel Course for Management Institute in …
27th April 2022 ,Noida , India : Pocket Portal Academy , an Ed Tech Company specializing in conducting Industry Use Case Courses for Management Institutes in areas of Data Science , Artificial Intelligence, Machine & Deep Learning using tools like Advance Excel , Python , R , SPSS , Orange and Statcraft conducted a 2 days 12 hours comprehensive Advance Excel Certification Program for PGDM (Post Graduate Diploma in Management
Global Multiple Myeloma Pipeline Market Analysis Report 2021 and Forecast to 202 …
Global Multiple Myeloma Pipeline Market Professional Survey Research The global “Multiple Myeloma Pipeline Market” research report focuses on a condensed major statistical summary for the sector, as it provides our readers with a valuable resource for navigating the market’s challenges. The study includes an extensive list of factors such as global distribution, company data, market size, and market factors that influence global contributions. In addition, the market size study focuses on